Log In
Print
BCIQ
Print
Print this Print this
 

MK-8808

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionBiosimilar of rituximab
Molecular Target CD20
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today